Biotechnology
Swiss companies operating in the same biotechnology industry
The list below has Swiss companies that operate under the same industry, biotechnology. The list helps track their performance, income statement, and more. Sorted by any necessary metric, it can show the most expensive stocks of the industry such as MODERNA INC or those with the best price dynamics like KUROS N, thus assisting in designing strategies of any focus.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 GISGILEAD SCIENCES | 71.8 B CHF | 58.007 CHF | −1.92% | 15 | 0.18 | 179.26 | 0.32 CHF | −92.01% | 4.67% | Health Technology | Buy |
 0QFMODERNA INC | 51.55 B CHF | 137.199 CHF | +3.97% | 10 | 0.08 | — | −14.14 CHF | −233.31% | 0.00% | Health Technology | Buy |
 22UABIONTECH SEDR | 21.247 B CHF | 91.500 CHF | +1.48% | 55 | 1.31 | 211.88 | 0.43 CHF | −98.15% | 0.00% | Health Technology | Buy |
 BM8BIOMARIN PHARMA | 13.648 B CHF | 70.994 CHF | −12.25% | 70 | 0.66 | 73.65 | 0.96 CHF | +183.03% | 0.00% | Health Technology | Buy |
 1CGCRISPR THERAPEUTIC | 4.377 B CHF | 54.514 CHF | +4.06% | 12 | 0.07 | — | −2.46 CHF | +60.09% | 0.00% | Health Technology | Buy |
 MORMORPHOSYS | 2.442 B CHF | 67.360 CHF | +1.89% | 100 | 0.78 | — | −12.48 CHF | −488.68% | 0.00% | Health Technology | Neutral |
 NVV1NOVAVAX INC | 2.272 B CHF | 17.270 CHF | −21.81% | 280 | 0.41 | — | −2.87 CHF | +78.22% | 0.00% | Health Technology | Buy |
 DYF1DYNAVAX TECHNOLOGI | 1.406 B CHF | 10.855 CHF | −1.32% | 500 | 0.58 | 222.83 | 0.05 CHF | −96.59% | 0.00% | Health Technology | Strong buy |
 PPGNPOLYPEPTIDE N | 1.072 B CHF | 32.45 CHF | −0.61% | 14.52 K | 0.67 | — | −1.52 CHF | −198.61% | 0.00% | Health Technology | Neutral |
| 8H0POLYPEPTIDE GROUP | 1.072 B CHF | 32.836 CHF | +1.46% | 19 | 0.16 | — | −1.52 CHF | −198.61% | 0.00% | Health Technology | Neutral |
 YTSNKUROS BIOSCIENCES | 364.81 M CHF | 9.785 CHF | +6.36% | 850 | 1.79 | — | −0.38 CHF | −63.13% | 0.00% | Health Technology | Strong buy |
| KURNKUROS N | 364.81 M CHF | 10.36 CHF | +13.60% | 558.352 K | 2.39 | — | −0.38 CHF | −63.13% | 0.00% | Health Technology | Strong buy |
 UQ1UNIQURE N.V. | 230.498 M CHF | 4.302 CHF | — | 1 K | — | — | −5.59 CHF | −82.70% | 0.00% | Health Technology | Buy |
 6MLMOLECULAR PARTNERS | 137.374 M CHF | 3.648 CHF | +9.88% | 32 | 0.02 | — | −1.78 CHF | −19.89% | 0.00% | Health Technology | Neutral |
| MOLNMOLECULAR PARTNERS N | 137.374 M CHF | 3.745 CHF | −0.13% | 10.007 K | 0.32 | — | −1.78 CHF | −19.89% | 0.00% | Health Technology | Neutral |
 GBYSANGAMO THERAPEUTI | 106.153 M CHF | 0.516 CHF | +7.50% | 2 K | — | — | −1.67 CHF | −123.52% | 0.00% | Health Technology | Buy |
 1S9SERES THERAPEUTICS | 82.83 M CHF | 0.957 CHF | +9.75% | 250 | 0.26 | — | −0.55 CHF | +74.01% | 0.00% | Health Technology | Buy |